Funding for this research was provided by:
Vifor Pharma International AG
Text and Data Mining valid from 2019-10-03
First Online: 3 October 2019
Compliance with ethical standards
: This study was funded by Vifor Pharma International AG.
: Stefan Wohlfeil was an employee of Vifor Pharma Management Ltd during the planning and execution of the study and holds shares in Vifor Pharma. Lennart Nathell is a former employee of Vifor Pharma; during the planning, execution, and publishing of the study Lennart worked for a company on a contract with Vifor Pharma Management Ltd. Vifor Pharma is the manufacturer of Ferinject<sup>®</sup> (ferric carboxymaltose) and Venofer<sup>®</sup> (iron sucrose). Annegret Gohlke is employee of IQVIA, which received funding from Vifor Pharma International AG for the conduct of the study.
: Reports on anaphylactic reactions, anaphylactic shocks, anaphylactoid reactions, and anaphylactoid shocks can be publicly accessed via EudraVigilance: ExternalRef removed.
: Data derived from EudraVigilance: The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the EMA or one of its committees or working parties.